WT
EW icon

Washington Trust’s Edwards Lifesciences EW Stock Holding History

Washington Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54
Closed -$3.91K – 401
2025
Q1 		$3.91K Sell
54
-19
-26% -$1.36K ﹤0.01% 676
2024
Q4 		$5.41K Sell
73
-502
-87% -$35.1K ﹤0.01% 726
2024
Q3 		$37.9K Sell
575
-182
-24% -$13.2K ﹤0.01% 493
2024
Q2 		$69.9K Buy
757
+18
+2% +$1.59K ﹤0.01% 397
2024
Q1 		$70.6K Buy
739
+11
+2% +$924 ﹤0.01% 404
2023
Q4 		$55.5K Sell
728
-2
-0.3% -$139 ﹤0.01% 414
2023
Q3 		$50.6K Hold
730
– – ﹤0.01% 389
2023
Q2 		$68.9K Buy
730
+26
+4% +$2.26K ﹤0.01% 373
2023
Q1 		$58.2K Buy
704
+6
+0.9% +$472 ﹤0.01% 390
2022
Q4 		$52.1K Buy
698
+500
+253% +$38.5K ﹤0.01% 398
2022
Q3 		$16K Sell
198
-33
-14% -$3.17K ﹤0.01% 578
2022
Q2 		$22K Sell
231
-264
-53% -$27.3K ﹤0.01% 534
2022
Q1 		$59K Sell
495
-3
-0.6% -$337 ﹤0.01% 407
2021
Q4 		$64K Sell
498
-67,966
-99% -$7.93M ﹤0.01% 399
2021
Q3 		$7.75M Buy
68,464
+26
+0% +$2.97K 0.22% 113
2021
Q2 		$7.09M Buy
68,438
+267
+0.4% +$25.2K 0.2% 112
2021
Q1 		$5.7M Sell
68,171
-40
-0.1% -$3.38K 0.18% 118
2020
Q4 		$6.22M Buy
68,211
+2,321
+4% +$193K 0.2% 111
2020
Q3 		$5.26M Sell
65,890
-288
-0.4% -$22.5K 0.19% 109
2020
Q2 		$4.57M Buy
66,178
+655
+1% +$46.5K 0.19% 112
2020
Q1 		$4.12M Buy
65,523
+17,277
+36% +$1.25M 0.2% 111
2019
Q4 		$3.75M Buy
+48,246
New +$3.77M 0.15% 123
2018
Q3 		– Sell
-1,872
Closed -$91K – 421
2018
Q2 		$91K Buy
+1,872
New +$87.4K ﹤0.01% 332

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Washington Trust's EW Position: Q2 2025 in Review

Washington Trust sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 54 shares — an estimated $3.91K sold.

Washington Trust first reported a position in EW in Q2 2018 and held it in 23 quarters. The position peaked at $7.75M in Q3 2021. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Washington Trust reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 54 Edwards Lifesciences shares in Q2 2025, an estimated $3.91K.
  • Washington Trust first reported a position in Edwards Lifesciences in Q2 2018 and held it in 23 quarters.
  • Washington Trust's Edwards Lifesciences position peaked at $7.75M in Q3 2021.
  • 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.